Skip to main content

Five-minute Q & A: Data & analytics for planning

Computer with graphs and analytics displayed. Notepad and phone sit next to computer.

New trends and change agents are increasingly challenging health systems’ volume and revenue growth. To compete and stay relevant, they must take a more balanced approach to their near-, mid-and long-term growth.

DataGen and Sg2 recently joined forces to host Optimizing strategic planning for revenue growth: DataGen and Sg2 resources. This webinar featured customers' experiences using Sg2's suite of analytical tools and how, when partnered with DataGen's customized customer service and training, these tools helped their organization optimize its strategic planning for enhanced revenue growth. 

We broke down five common questions asked during the session.

1.       What disruptors are you keeping an eye on? 

  • We are keeping an eye on four major disruptors: Retail clinics, big tech/digital, VC-backed medical groups and payers as providers. 

2.       What downstream effects have these disruptors had on inpatient volumes? 

  • Nationally, IP utilization has remained well below pre-pandemic levels through Q2 2022. Through Sg2’s partnership with Strata Decision Technology, we compared adult quarterly volumes from 2019 vs. 2020-2022. Across the country, there is a decline of 10% when you include COVID-19 diagnosis and 14% when you exclude COVID-19 diagnosis. 

3.       What downstream effects have these disruptors had on outpatient volumes? 

  • Outpatient volume demonstrates recovery and growth beyond pre-pandemic levels. According to Strata Decision Technology, the adult quarterly volumes, including COVID-19 from 2019 vs. 2020-2022, revealed OP, OP surgery and E&M are all up between 4% and 5%, while ED visits are flat.  

4.       What are some key 2022 forecast considerations? 

  • Endemic COVID-19 
  • Rising patient acuity  
  • Shift to OP slowing 
  • Expanded care at home capabilities 
  • Record MA enrollment 

5.       What does today’s winning growth portfolio look like? 

  • Near-term: Drive an optimal patient mix through the existing footprint. 
  • Mid-term: Increase revenue and margin capture for patients you serve. 
  • Long-term: Evolve and expand the footprint to win more patients. 
Struggling to get a comprehensive view of your market, competitive position and growth opportunities to guide your strategic planning? Check out how DataGen's partnership with Sg2 can help.


Popular posts from this blog

Alternative payment models: Strategies for success

In this edition of DataGen Insights, we look at how alternative payment model participants can ensure their processes and workflows are optimally set up for success. To help, DataGen listed the top three strategies all providers participating in APMs can employ and created a handy checklist to enable maximum returns and reduce financial risk. Please explore our website to learn more about our  products and services .  Download DataGen Insights today .  We hope you enjoy!

Why it's critical for Primary Care First participants to control and understand leakage

Patients' primary care visits outside of their attributed primary care office, also called “leaked” patient visits, can have unintended consequences for Primary Care First participants. Beginning July 2022, PCF Cohort 1 will face a reduction in population-based payments based on their leakage rate. The payment adjustment will be based on their 2021 claims data and will roll forward quarterly. To calculate your leakage rate, divide the number of qualifying visits and services your attributed beneficiaries have made to care centers outside of your practice (for example, visits to urgent care centers) by the total number of qualifying visits and services your attributed beneficiaries have made. Calculating primary care leakage with claims data alone comes with some unintended challenges. Unfortunately, some circumstances can unfairly and negatively impact a practice’s leakage rate: Nuances classifying care delivered by provider team members: It’s difficult to distinguish

CMMI’s New Enhancing Oncology Model – Deadline Approaching

As the final at-risk period for the Oncology Care Model was closing at the end of June, the Center for Medicare and Medicaid Innovation announced its new Enhancing Oncology Model (EOM). EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment.  What is EOM? EOM is a voluntary, five-year model set to begin July 1, 2023. Patients undergoing chemotherapy for the treatment of cancer will trigger six-month episodes of care.  Eligible EOM participants include physician group practices with at least one Medicare-enrolled physician or a non-physician practitioner who furnishes evaluation and management services to Medicare beneficiaries receiving chemotherapy for cancer treatment.  EOM participants are required to implement eight participant redesign activities to drive care transformation in their practice. Examples include the provision of patient navigation, 24/7 access to an appropriate c